|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/485 | |
| A61P 25/04 | |||
| A61P 25/22 | |||
| A61P 25/24 |
| (11) | Number of the document | 2790702 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12830900.2 |
| Date of filing the European patent application | 2012-12-14 | |
| (97) | Date of publication of the European application | 2014-10-22 |
| (45) | Date of publication and mention of the grant of the patent | 2020-04-01 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2012/002900 |
| Date | 2012-12-14 |
| (87) | Number | WO 2013/088243 |
| Date | 2013-06-20 |
| (30) | Number | Date | Country code |
| 201161576233 P | 2011-12-15 | US |
| (72) |
DEAVER, Daniel, US
EHRICH, Elliot, US
|
| (73) |
Alkermes Pharma Ireland Limited,
Connaught House 1 Burlington Road, Dublin 4,
IE
|
| (54) | COMPOSITIONS OF BUPRENORPHINE AND MU-OPIOID RECEPTOR ANTAGONISTS |
| COMPOSITIONS OF BUPRENORPHINE AND MU-OPIOID RECEPTOR ANTAGONISTS |